Micafungin and Lexapro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micafungin (micafungin sodium) and Lexapro (escitalopram oxalate). Common drug interactions include aspartate aminotransferase increased among females and respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Micafungin and Lexapro. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

On Jul, 15, 2026

44 people who take Micafungin and Lexapro together, and have interactions are studied.

Micafungin and Lexapro drug interactions.

What are the common drug interactions of Micafungin and Lexapro, by gender? *:

female:

Aspartate aminotransferase increased
Bile duct stone
Blood alkaline phosphatase increased
Fungaemia (fungi circulate in the blood)
Hepatic failure (liver failure)
Hypertransaminasaemia
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Abdominal pain upper
Acute respiratory failure

male:

Respiratory failure (inadequate gas exchange by the respiratory system)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Constipation
Cough
Cystic fibrosis (disease of the secretary glands)
Diarrhoea
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)

What are the common drug interactions of Micafungin and Lexapro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Blast cell count increased
Disease progression
Enterococcal infection
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hepatic failure (liver failure)
Respiratory failure (inadequate gas exchange by the respiratory system)

20-29:

Respiratory failure (inadequate gas exchange by the respiratory system)
Thrombocytopenia (decrease of platelets in blood)
Abdominal pain upper
Injection site pain

30-39:

Aspartate aminotransferase increased
Bile duct stone
Blood alkaline phosphatase increased
Fungaemia (fungi circulate in the blood)
Hepatic failure (liver failure)
Hypertransaminasaemia
Pulmonary congestion (congestion in the lungs)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Pericardial effusion (fluid around the heart)

40-49:

Death
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Fluid overload (too much fluid in the blood)
Hypophagia (reduced food intake)
Infection
Stem cell transplant
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Pancreatitis acute (sudden inflammation of pancreas)

60+:

Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Febrile neutropenia (fever with reduced white blood cells)
Enterococcal infection
Fluid overload (too much fluid in the blood)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Metapneumovirus infection (infection with human metapneumovirus)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the existing conditions these people have? *

Pain: 30 people, 68.18%
Nausea (feeling of having an urge to vomit): 24 people, 54.55%
Asthma: 16 people, 36.36%
High Blood Pressure: 16 people, 36.36%
Insomnia (sleeplessness): 14 people, 31.82%
Stress And Anxiety: 13 people, 29.55%
Hypokalemia (low potassium): 11 people, 25.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 11 people, 25.00%
Fungal Infection: 10 people, 22.73%
Agitation (state of anxiety or nervous excitement): 10 people, 22.73%

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin and Lexapro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously